Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

Life expectancy in patients with multiple myeloma is increasing because of the availability of an increasing number of novel agents with various mechanisms of action against the disease. However, the disease remains incurable in most patients because of the emergence of resistant clones, leading to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mayo Clin Proc
Main Authors: Dingli, David, Ailawadhi, Sikander, Bergsagel, P. Leif, Buadi, Francis K., Dispenzieri, Angela, Fonseca, Rafael, Gertz, Morie A., Gonsalves, Wilson I., Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis, Kumar, Shaji K., Kyle, Robert A., Lacy, Martha Q., Leung, Nelson, Lin, Yi, Lust, John A., Mikhael, Joseph R., Reeder, Craig B., Roy, Vivek, Russell, Stephen J., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Zeldenrust, Stephen R., Rajkumar, S. Vincent, Chanan Khan, Asher A.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554888/
https://ncbi.nlm.nih.gov/pubmed/28291589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2017.01.003
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki